Cellnovo’s Diabetes Management System Featured in NHS Alliance Programme ‘Communities of Care’

Regulatory News:

Cellnovo Group (Paris:CLNV) ("Cellnovo” CLNV: EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today announces that its diabetes system has been featured as an exemplar in the NHS Alliance’s news-style programme entitled ‘Communities of Care’, produced in partnership with ITN Productions. The programme was premiered at the NHS Alliance’s event hosted in ITN Productions’ studio last night.

At the event, which gathered members of the NHS Alliance and key healthcare policy makers, Cellnovo’s diabetes system was highlighted as an innovative technology to help empower individuals and communities to care for themselves and one another, thus reducing the burden on the national healthcare system.

The NHS Alliance is an independent organisation representing providers of care to the UK’s National Health Service (NHS). The film will also be shown at the NHS Alliance Annual Conference in early 2016, where the Alliance’s agenda for 2016 will be set.

Sophie Baratte, Chief Executive Officer, commented: "400,000 people in the UK are living with type 1 diabetes. Our innovative technology helps them take control of their health. It helps healthcare professionals choose the best model of care and it helps improve outcomes for healthcare systems that are increasingly faced with constrained resources. "Communities of Care,” represents Cellnovo’s mission in promoting accountable care organisations and reducing the burden on healthcare systems. We are pleased to take part in this important initiative and be featured so significantly in this important forum.”

Julian Shapley, Chief Scientific Officer, said "We have created a state-of the art technology that is small, discreet and wearable under any clothing. It uses the modern technologies of tele-medecine and e-health to ensure that the user can become a partner at the center of their treatment. This is the way forward in helping people take control of their condition.”

To view the programme, visit: https://youtu.be/JT7ESrlpojo

About the NHS Alliance

NHS Alliance is an independent, not-for-profit, leadership organisation representing progressive providers of care outside the hospital setting. A recognised and highly regarded engine for change, NHS Alliance provides an influential voice for its members, and is instrumental in helping shape health agendas and policy. An early exponent of clinical commissioning, it now works closely with providers and communities to identify and share the kinds of solutions we need to sustain the NHS in times of unparalleled austerity. It also provides practical support to help drive the innovation it advocates.

www.nhsalliance.org

About Cellnovo

An independent medical technology company specialising in diabetes, Cellnovo has developed and markets the first mobile, connected all-in-one diabetes management system that helps make life easier for patients. Compact, tubeless, intuitive and entirely connected, Cellnovo’s insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real-time.

For further information please visit www.cellnovo.com

About ITN Productions

ITN Productions is ITN’s bespoke production hub producing creative and commercially valuable content for the corporate, commercial, broadcast and digital sectors. Industry News forms part of this offering and is a communications tool for leading industry bodies and national associations produced in a broadcast news programme format, including interviews, news-style items and sponsored editorial profiles.

www.itnproductions.co.uk

Cellnovo is listed on Euronext, Compartment C
ISIN: FR0012633360 – Ticker: CLNV

View source version on businesswire.com: http://www.businesswire.com/news/home/20151208006503/en/